News About: Pharm. Industry
Novartis only to avoid problems, “We didn’t know about KRW 18 billion”The prosecution has once again exposed hidden connections between pharmaceutical companies and doctors in large general hospitals. The subject of the issue is a large global pha...
|
Reason why Novartis’ trial will become Moon’s battle
Hak-sun Moon(47), a former CEO of Novartis Korea, was indicted without detention only in 11 months after the appointment.
The Seoul Western District Prosecutor’s Office is suspicious on the former Novartis Korea CEO...
Silent Alvogen Korea’s similar packaging causes dispending mistakesMost of the Avogen Korea’s products were observed to distract the pharmacy world similar packaging and design.
The company, however, have not shown responses to the complaints ...
|
Multinational pharma companies’ MRs receive KRW 60 million as daily expenses
It was observed multinational pharmaceutical companies’ medical representatives(MRs) have received KRW 60 thousand at most as daily activity costs, and some companies have paid up to KRW 3 million as self-development ...
Co-marketing benefits pharmaceutical companies, but not over defective products
While domestic pharmaceutical companies cannot ignore sales, pharmacies and the distribution industry are sales tools for multinational companies. However, they have had so many complaints since co-marketed and co-pro...
Pharmaceutical public advertisement market hit peak
The pharmaceutical public advertising market has hit its peak. Advertising expenses of major pharmaceutical companies focusing on public advertisements were increased by 80% this year. With stabilization in the market...
“Kim Young-ran Law is double torture on MRs in pharmaceutical field”
The Kim Young-ran Law will be enforced from the 28th of September on medical representatives(MRs) who are already suffering from the Fair Racing Enforcement and the Compliance Program in the pharmaceutical industry.
...
34 people including Novartis’ CEOs & doctors prosecuted of illegal rebatesAt the prosecution’s rebate investigation on a multinational pharmaceutical company, Novartis, which brought a major issue in the pharmaceutical industry in the first half of th...
|
Loyal(?) Novartis protects ‘precious’ hospital doctors“It was so obvious. As expected, they are only able to cut tails, never a body.”
This was a reaction towards the rebate investigation result against a large global company, Nov...
|
Pharmaceutical field’s employment market is hot as sun
As the unemployment problem is getting intensified due to the depression in the real economy overall, the pharmaceutical industry’s job creation capability has drawn attention.
44 of 100 domestic listed companies(44%...
